Kazunobu Ouchi

Prof. Dr. Kazunobu Ouchi

Department of Pediatrics, Kawasaki Medical School, Okayama 701-0192, Japan

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2009 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
NMNaoyuki Miyashita
Naoyuki Miyashita
TSTadaaki Sugiu
Tadaaki Sugiu
YKYasuhiro Kawai
Yasuhiro Kawai
KOKeiko Oda
Keiko Oda
TYTetsuya Yamaguchi
Tetsuya Yamaguchi
MOMikio Oka
Mikio Oka
The Japanese Respiratory Society guidelines propose a differential diagnosis for atypical pneumonia and bacterial pneumonia using a scoring system for the selection of appropriate antibiotic. In order to improve this scoring system, the guidelines are seeking new specific parameter. The purpose of this study was to clarify the pattern of abnormalities with Mycoplasma pneumoniae pneumonia on chest computed tomography (CT) and whether the radiographic findings could distinguish M. pneumoniae pneumonia from Streptococcus pneumoniae pneumonia.

31 May 2012 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TGthe Atypical Pathogen Study Group
the Atypical Pathogen Study Group
NMNaoyuki Miyashita
Naoyuki Miyashita
YKYasuhiro Kawai
Yasuhiro Kawai
HAHiroto Akaike
Hiroto Akaike
Kazunobu OuchiKazunobu Ouchi
Kazunobu Ouchi
NONiro Okimoto
Niro Okimoto
Although the prevalence of macrolide-resistant Mycoplasma pneumoniae isolates in Japanese pediatric patients has increased rapidly, there have been no reports concerning macrolide-resistant M. pneumoniae infection in adolescents aged 16 to 19 years old. The purpose of this study was to clarify the prevalence and clinical characteristics of macrolide-resistant M. pneumoniae in adolescent patients with community-acquired pneumonia.

24 March 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Tomohiro OishiTomohiro Oishi
Tomohiro Oishi
Kazunobu OuchiKazunobu Ouchi
Kazunobu Ouchi
Among Mycoplasma pneumoniae (MP) is one of the major pathogens causing lower respiratory tract infection. Macrolide-resistant Mycoplasma pneumoniae (MRMP) isolates have been increasing and has become a global concern, especially in East Asian countries. This affects the treatment of MP infection; that is, some patients with MRMP infections fever cannot be controlled despite macrolide therapy. Therefore, alternative therapies, including secondary antimicrobials, including tetracyclines, fluoroquinolones, or systemic corticosteroids, were introduced. However, there are insufficient data on these alternative therapies. Thus, this article provides reviews of the recent trends in the epidemiology, diagnosis, and treatment of MRMP.

15 January 2003 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
Kazunobu OuchiKazunobu Ouchi
Kazunobu Ouchi
YSYoichi Suzuki
Yoichi Suzuki
TSTaro Shirakawa
Taro Shirakawa
FKFumio Kishi
Fumio Kishi
Since its first description in Japan >30 years ago, Kawasaki disease (KD) has been reported worldwide. Although an infectious etiology is suspecte

1 February 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Open access
YNYoshitaka Nakamura
Yoshitaka Nakamura
Tomohiro OishiTomohiro Oishi
Tomohiro Oishi
KKKazunari Kaneko
Kazunari Kaneko
TKTsuyoshi Kenri
Tsuyoshi Kenri
TTTakaaki Tanaka
Takaaki Tanaka
Kazunobu OuchiKazunobu Ouchi
Kazunobu Ouchi
Mycoplasma pneumoniae contributes to numerous pneumonia cases among children and young adults. Therefore, this study aimed to investigate the prevalence of M. pneumoniae infections among Japanese children, occurring since 2008. Nasopharyngeal swab specimens were obtained from all cases, following which real-time PCR was performed to identify M. pneumoniae. Further, the p1 genotypes of isolates were determined using the PCR restriction fragment length polymorphism typing method. The annual rate of macrolide-resistant M. pneumoniae (MRMP) infections peaked at 81.8% in 2012 and decreased annually until 2015. Although the infection rate increased to 65.3% in 2016, it decreased again to 14.3% in 2018. Although >90% of isolates harbored the type 1 genotype until 2012, this rate decreased, and approximately 80% harbored p1 genotypes other than type 1 in 2018. Furthermore, the occurrence rate of MRMP among the type 1 isolates was very high (82.4%), whereas that among p1 genotypes other than type 1 was very low (6.5%). MRMP occurrence potentially decreased owing to changes in not only antibiotic usage but also in the distribution of p1 genotype among isolates.

11 March 2013 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
NMNaoyuki Miyashita
Naoyuki Miyashita
HAHiroto Akaike
Hiroto Akaike
HTHideto Teranishi
Hideto Teranishi
YKYasuhiro Kawai
Yasuhiro Kawai
Kazunobu OuchiKazunobu Ouchi
Kazunobu Ouchi
NONiro Okimoto
Niro Okimoto
Several symptoms are classically thought to be suggestive of pertussis in children, but the diagnostic value of these symptoms in adolescent and adult patients is unclear. We evaluated the accuracy of the clinical findings for the early presumptive diagnosis of pertussis in adolescent and adult patients. Furthermore, we measured fractional exhaled nitric oxide (FeNO) with regard to whether we could distinguish eosinophilic inflammation of the airway and pertussis. FeNO is not expected to be associated with pertussis.